Craig M Goodwin

9PUBLICATIONS
100CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Oct 08, 2026
Concurrent AXL Inhibition Enhances RAS and ERK Inhibitor Efficacy in KRAS -mutant Pancreatic and Lung Cancer.

|Nov 17, 2025
CRISPR-Cas9 Screening Identifies Resistance Mechanisms to KRAS Inhibition in Pancreatic Cancer.

Szu-Aun Long, Haley Todd, Grace Goodhart

|Jun 06, 2024
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers.

Jeffrey A Klomp, Jennifer E Klomp, Clint A Stalnecker

|Dec 19, 2023
RHOAL57V drives the development of diffuse gastric cancer through IGF1R-PAK1-YAP1 signaling.

Antje Schaefer, Richard G Hodge, Haisheng Zhang

|Nov 08, 2022
Combination Therapies with CDK4/6 Inhibitors to Treat KRAS-Mutant Pancreatic Cancer.

Craig M Goodwin, Andrew M Waters, Jennifer E Klomp

|Aug 09, 2022
Functional and biological heterogeneity of KRASQ61 mutations.

Minh V Huynh, G Aaron Hobbs, Antje Schaefer

Pageof 2

Frequent Collaborators

8 joint publications

Adrienne D Cox

6 joint publications

Channing J Der

5 joint publications

Andrew M Waters

5 joint publications

Kirsten L Bryant